Sugi Predict

Sugi Predict / Compounds / SCHEMBL4170824

SCHEMBL4170824

SCHEMBL4170824

NC(C(=O)O)C(O)c1c[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ MPO P05164 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ PMP22 Q01453 1/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ GPR84 Q9NQS5 4/20 0.50
▸ MGAM O43451 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ SI P14410 2/20 0.50
▸ MGAM2 Q2M2H8 2/20 0.50
▸ NOD2 Q9HC29 1/20 0.50
▸ FFAR1 O14842 2/20 0.47
▸ HTR2A P28223 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184199 1.00 MAPT (0.54) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL29263805 0.86 MEN1 (0.52) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL29263804 0.86 MEN1 (0.52) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL7059264 0.85 MEN1 (0.49) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL5289034 0.84 MEN1 (0.51) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL195995 0.84 GPR84 (0.53) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL5913085 0.84 GPR84 (0.53) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL195996 0.84 GPR84 (0.53) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL6588456 0.84 GPR84 (0.53) MAPTMEN1KMT2AKDM4ELMNA
SCHEMBL31000529 0.84 GPR84 (0.53) MAPTMEN1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3335720-A1 C-DI-GMP BINDING PEPTIDES Universität Basel (CH) 2018-06-20 — — EP claimed
US-5081225-A Novel antibiotic, janthinocin E. R. SQUIBB & SONS, INC. (US) 1992-01-14 — — US claimed
JP-2270896-A — — None — — JP disclosed
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 — — EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 — — US disclosed
US-11535634-B2 Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-12-27 — — US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-10918735-B2 Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-02-16 — — US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 — — US disclosed
WO-2020247054-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-12-10 — — WO disclosed
US-20200385407-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2020-12-10 — — US disclosed
US-20070218525-A1 Process for Producing Dipeptides KYOWA HAKKO KOGYO CO., LTD. 2007-09-20 — — US disclosed
US-20070128687-A1 Comprises enzyme source and diketopiperazine, wherein aspartic acid and phenylalanine are condensed with each other KYOWA HAKKO BIO CO., LTD. (JP) 2007-06-07 — — US disclosed
EP-1760152-A1 PROCESS FOR PRODUCING DIPEPTIDE KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-03-07 — — EP disclosed
EP-1736540-A1 PROCESS FOR PRODUCING DIPEPTIDES KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-12-27 — — EP disclosed
EP-1698703-A1 PROCESS FOR PRODUCING DIPEPTIDE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-06 — — EP disclosed
US-20030105281-A1 Antimicrobial peptides isolated from mast cells NORTH CAROLINA STATE UNIVERSITY 2003-06-05 — — US disclosed
WO-2002014345-A2 ANTIMICROBIAL PEPTIDES ISOLATED FROM MAST CELLS NORTH CAROLINA STATE UNIVERSITY (US) 2002-02-21 — — WO disclosed
US-5081225-A Novel antibiotic, janthinocin E. R. SQUIBB & SONS, INC. (US) 1992-01-14 — — US disclosed
JP-H02270896-A JANTHINOMYCIN E R SQUIBB & SONS INC 1990-11-05 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10918735-B2 Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment IDO1, IDO2, INMT MAPT 530/4885MEN1 877/4885KMT2A 2418/4885
US-11535634-B2 Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof DNPEP, DHPS, NPEPPS MAPT 2970/4885MEN1 2262/4885KMT2A 1179/4885
US-20200385407-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF DNPEP, DHPS, NPEPPS MAPT 2970/4885MEN1 2262/4885KMT2A 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.